Novo and Sanofi have backed a series A round for Inozyme Pharma, which is developing treatments for rare diseases affecting infants.

Tencent has backed antimicrobial therapy developer Locus Biosciences in a $19m round that will fund the company's first in-human clinical trial.

Pep-Therapy has now raised $2.9m to deliver peptide-based cancer drugs that further research from Université Pierre et Marie Curie, Institut Curie and Inserm.

Imec spinout LynxCare has collected funding from investors including government-owned PMV and VLaio.

The incubator will welcome spinouts from seven universities to its program, set to launch in mid-October.

Senior-focused hardware and software developer Halove Technology has raised $31.7m in a round featuring We Doctor Group.

The cloud video hosting platform has raised $31.4m, six years after closing a Steamboat Ventures-led series B round.

Sedgwick Claims Management Services-backed LeanTaas has secured $26m to continue development of its healthcare management platform.